Last updated 57 days ago
To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia
360 patients around the world
Available in Puerto Rico, Spain, Chile, Argentina, United States
89bio, Inc.
1Research sites
360Patients around the world
This study is for people with
Hypertriglyceridemia
Severe Hypertriglyceridemia
Requirements for the patient
From 22 Years
All Gender
Medical requirements
StudyENTRUST
Sponsor89bio, Inc.
Conditions
Severe Hypertriglyceridemia
Requirements
From 22 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT05852431
